Ethical aspects of cancer screening

Cancer Forum

Volumn 40, Issue 2, 2016, Pages

  Carter, Stacy M ^a  

^a UNIVERSITY OF SYDNEY   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

CANCER EPIDEMIOLOGY; CANCER RISK; CANCER SCREENING; CANCER SUSCEPTIBILITY; ETHICS; FEAR; HIGH INCOME COUNTRY; HUMAN; PSYCHOLOGICAL WELL-BEING; PUBLIC HEALTH;

EID: 85000788727     PISSN: 0311306X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (66)

1. Wilson JMG, Jungner G. Principles and practice of screening for disease. Geneva: World Health Organisation, 1968.
2. Juth N, Munthe C. The Ethics of Screening in Health Care and Medicine: Serving Society or Serving the Patient?: Springer; 2012.
3. Chan ECY. Promoting an ethical approach to unproven screening imaging tests. Journal of the American College of Radiology. 2005;2(4):311-20.
4. Carter SM, Williams J, Parker L, et al. Screening for Cervical, Prostate, and Breast Cancer. Am J Prev Med. 2015;49(2):274-85.
5. Burger IM, Kass NE. Screening in the Dark: Ethical Considerations of Providing Screening Tests to Individuals When Evidence is Insufficient to Support Screening Populations. Am J Bioeth. 2009;9(4):3-14.
6. Borland R, Donaghue N, Hill D. Illnesses that Australians most feared in 1986 and 1993. Aust J Public Health. 1994;18(4):366-9.
7. Lee V, Loiselle CG. The salience of existential concerns across the cancer control continuum. Palliat Support Care. 2012;10(2):123-33.
8. Lupton D. Femininity, responsibility, and the technological imperative - discourses on breast-cancer in the Australian press. Int J Health Serv. 1994;24(1):73-89.
9. Hofmann B. Is there a technological imperative in health care? Int J Technol Assess Health Care. 2002;18(3):675-89.
10. Schwartz LM, Woloshin S, Fowler FJ, et al. Enthusiasm for cancer screening in the United States. Jama-Journal of the American Medical Association. 2004;291(1):71-8.
11. Livingston P, Wakefield M, Elwood JM. Community attitudes towards the early detection of cancer in Victoria, Australia. Aust N Z J Public Health. 2007;31(1):26-9.
12. Williams JH, Carter SM, Rychetnik L. 'Organised' cervical screening 45 years on: How consistent are organised screening practices? Eur J Cancer. 2014;50(17):3029-38.
13. Verweij M, Dawson A. The meaning of 'public' in 'public health'. In: Dawson A, Verweij M, editors. Ethics, prevention and public health. Oxford: Oxford University Press. 2007:13-29.
14. Kass NE. An ethics framework for public health. Am J Public Health. 2001;91(11):1776-82.
15. Kass NE. Public health ethics: From foundations and frameworks to justice and global public health. Journal of Law Medicine & Ethics. 2004;32(2):232-42.
16. Wilson J. Towards a normative framework for public health ethics and policy. Public Health Ethics. 2009;2(2):184.
17. Upshur REG. Principles for the justification of public health intervention. Can J Public Health. 2002;93(2):101-3.
18. Childress JF, Faden RR, Gaare RD, et al. Public health ethics: Mapping the terrain. Journal of Law Medicine & Ethics. 2002;30(2):170-8.
19. Entwistle VA, Carter SM, Trevena L, et al. Communicating about screening. Br Med J. 2008;337(7673):3.
20. Entwistle VA, Carter SM, Cribb A, et al. Supporting patient autonomy: the importance of clinician-patient relationships. J Gen Intern Med. 2010; Jul. 25(7):741-5.
21. Beauchamp TL, Childress JF. Principles of Biomedical Ethics. Cary, NC: Oxford University Press USA; 2008.
22. Australian Government: Department of Health. Cancer Screening. 2015 [cited 2015 Dec. 4]; Available from: http://www.cancerscreening.gov. au/.
23. Harris RP, Sheridan SL, Lewis CL, et al. The harms of screening: A proposed taxonomy and application to lung cancer screening. JAMA Internal Medicine. 2014;174(2):281-6.
24. Hersch J, Jansen J, Barratt A, et al. Women's views on overdiagnosis in breast cancer screening: a qualitative study. BMJ. 2013;346.
25. Plutynski A. Ethical Issues in Cancer Screening and Prevention. J Med Philos. 2012;37(3):310-23.
26. Delatycki MB. The ethics of screening for disease. Pathology. 2012;44(2):63-8.
27. Carter SM, Rogers W, Heath I, et al. The challenge of overdiagnosis begins with its definition. BMJ. 2015;350:doi 10.1136/bmj.h869.
28. Marcus PM, Prorok PC, Miller AB, et al. Conceptualizing Overdiagnosis in Cancer Screening. J Natl Cancer Inst. 2015;107(4).
29. Hillman BJ. Economic, legal, and ethical rationales for the ACRIN National Lung Screening Trial of CT screening for lung cancer. Acad Radiol. 2003;10(3):349-50.
30. Parker L, Rychetnik L, Carter S. Values in breast cancer screening: an empirical study with Australian experts. BMJ Open. 2015;5(5).
31. Pickles K, Carter SM, Rychetnik L. Doctors' approaches to PSA testing and overdiagnosis in primary healthcare: a qualitative study. BMJ open. 2015;5(3):e006367.
32. Cantor SB, Volk RJ, Cass AR, et al. Psychological benefits of prostate cancer screening: the role of reassurance. Health Expect. 2002;5(2):104-13.
33. Williams JH, Carter SM, Rychetnik L. Information provision in cervical screening in Australia. Med J Aust. 2014;201(5):295-7.
34. Philips BU, Chambers DL, Whiting LH, et al. Ethical issues in communitybased cancer control: Considerations in designing interventions. Fam Community Health. 2001;23(4):62-74.
35. Australian Institute of Health and Welfare. Leading causes of death. Canberra: AIHW; 2015 [cited 2015 Dec. 11]; Available from: http://www.aihw.gov. au/deaths/leading-causes-of-death/.
36. Jørgensen KJ, Gøtzsche PC. Content of invitations for publicly funded screening mammography. BMJ: British Medical Journal. 2006;332(7540):538-41.
37. van Dam L, Bretthauer M. Ethical issues in colorectal cancer screening. Best Pract Res Clin Gastroenterol. 2014;28(2):315-26.
38. Elmore JG, Barton MB, Moceri VM, et al. Ten-Year Risk of False Positive Screening Mammograms and Clinical Breast Examinations. N Engl J Med. 1998;338(16):1089-96.
39. Brodersen J, Siersma VD. Long-Term Psychosocial Consequences of False-Positive Screening Mammography. The Annals of Family Medicine. 2013;11(2):106-15.
40. Parker LM, Rychetnik L, Carter SM. The role of communication in breast cancer screening: a qualitative study with Australian experts. BMC Cancer. 2015 15(Oct. 19):741.
41. Raffle A, Gray M. Screening: evidence and practice. Oxford: Oxford University Press; 2007.
42. Zapka JG, Geller BM, Bulliard J-L, et al. Print information to inform decisions about mammography screening participation in 16 countries with population-based programs. Patient Educ Couns. 2006;63(1-2):126-37.
43. Schwartz PH, Meslin EM. The ethics of information: Absolute risk reduction and patient understanding of screening. J Gen Intern Med. 2008;23(6):867-70.
44. Breitsameter C. Medical decision-making and communication of risks: an ethical perspective. J Med Ethics. 2010;36(6):349-52.
45. Shaw D, Elger B. Evidence-based persuasion: An ethical imperative. JAMA. 2013;309(16):1689-90.
46. Womack C, Warren AY. Informed decision making for cancer screening - not all of the ethical issues have been considered... still. Cytopathology. 2003;14(3):165-6.
47. Haehnel P. Screening: ethical principles. Bull Cancer (Paris). 2001;88(4):407-10.
48. Hersch J, Barratt A, Jansen J, et al. Use of a decision aid including information on overdetection to support informed choice about breast cancer screening: a randomised controlled trial. The Lancet. 2015;385(9978):1642-52.
49. Crockett R, Wilkinson TM, Marteau TM. Social patterning of screening uptake and the impact of facilitating informed choices: Psychological and ethical analyses. Health Care Anal. 2008;16(1):17-30.
50. Millett C, Parker M. Informed decision making for cancer screening - not all of the ethical issues have been considered. Cytopathology. 2003;14(1):3-4.
51. Schwartz PH. Questioning the Quantitative Imperative Decision Aids, Prevention, and the Ethics of Disclosure. Hastings Cent Rep. 2011;41(2):30-9.
52. Degeling C, Rychetnik L, Pickles K, et al. What should happen before asymptomatic men decide whether or not to have a PSA test? A report on three community juries. Med J Aust. 2015;203(8):335.
53. Muscat DM, Morony S, Shepherd HL, et al. Development and field testing of a consumer shared decision-making training program for adults with low literacy. Patient Educ Couns. 2015;98(10):1180-8.
54. Smith SK, Kearney P, Trevena L, et al. Informed choice in bowel cancer screening: a qualitative study to explore how adults with lower education use decision aids. Health Expect. 2014;17(4):511-22.
55. Ragupathy R, Menkes DB. Prostate cancer screening and ethical use of limited resources. NZ Med J. 2013;126(1385):92-4.
56. Vineis P, Satolli R. From Figures to Values: The Implicit Ethical Judgements in our Measures of Health. Public Health Ethics. 2012;5(1):22-8.
57. Heath I. Who needs health care-the well or the sick? BMJ. 2005;330(7497):954-6.
58. Heath I. Role of fear in overdiagnosis and overtreatment-an essay by Iona Heath. BMJ. 2014;349:g6123
59. Heath I. Overdiagnosis: when good intentions meet vested interests-an essay by Iona Heath. BMJ. 2013;347:f6361.
60. Ramsey S, Blough D, Kirchhoff A, et al. Washington State Cancer Patients Found To Be At Greater Risk For Bankruptcy Than People Without A Cancer Diagnosis. Health Aff. 2013;32(6):1143-52.
61. Mondragon D, Brandon JE. Two major ethical issues in health education and promotion: Assessing stage of change and cancer screening. Fam Community Health. 2001;23(4):50-61.
62. Jansen LA. Ethical concerns relating to the detection and treatment of ovarian cancer. Gynecol Oncol. 2002;84(1):1-3.
63. Zehbe I, Maar M, Nahwegahbow AJ, et al. Ethical Space for a Sensitive Research Topic: Engaging First Nations Women in the Development of Culturally Safe Human Papillomavirus Screening. Journal of Aboriginal Health. 2012;8(1):41-50.
64. Verweij M. Preventive Medicine between Obligation and Aspiration. Dordrecht, The Netherlands: Kluwer Academic Publishers; 2000.
65. Moutel G, Duchange N, Darquy S, et al. Women's participation in breast cancer screening in France - an ethical approach. BMC Medical Ethics. 2014;15.
66. Parker L, Rychetnik L, Carter S. Values in breast cancer screening: an empirical study with Australian experts. BMJ Open. 2015;5(5):e006333.